CIFORADENANT

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C20H21N7O3
Molecular Weight	407.4258
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=CC=C(O1)C2=C3N=NN(CC4=NC(CO[C@H]5CCOC5)=CC=C4)C3=NC(N)=N2

InChI

InChIKey=KURQKNMKCGYWRJ-HNNXBMFYSA-N

InChI=1S/C20H21N7O3/c1-12-5-6-16(30-12)17-18-19(24-20(21)23-17)27(26-25-18)9-13-3-2-4-14(22-13)10-29-15-7-8-28-11-15/h2-6,15H,7-11H2,1H3,(H2,21,23,24)/t15-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C20H21N7O3
Molecular Weight	407.4258
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Adenosine A2a receptor 31 Target ID: CHEMBL251 Sources: https://www.ncbi.nlm.nih.gov/pubmed/30131376 \| https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-cpi-444	Antagonist 2849

C_max

Value	Dose	Analyte	Population
4.29 μg/mL OTHER https://www.sec.gov/Archives/edgar/data/1626971/000104746917001459/a2231221z10-k.htm	200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered:	CIFORADENANT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN
5.59 μg/mL OTHER https://www.sec.gov/Archives/edgar/data/1626971/000104746917001459/a2231221z10-k.htm	200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered:	CIFORADENANT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN
3.54 μg/mL OTHER https://www.sec.gov/Archives/edgar/data/1626971/000104746917001459/a2231221z10-k.htm	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered:	CIFORADENANT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN
4.06 μg/mL OTHER https://www.sec.gov/Archives/edgar/data/1626971/000104746917001459/a2231221z10-k.htm	100 mg 2 times / day multiple, oral dose: 100 mg route of administration: Oral experiment type: MULTIPLE co-administered:	CIFORADENANT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN

T_1/2

Value	Dose	Analyte	Population
10.2 h OTHER https://www.sec.gov/Archives/edgar/data/1626971/000104746917001459/a2231221z10-k.htm	200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered:	CIFORADENANT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN
3 h OTHER https://www.sec.gov/Archives/edgar/data/1626971/000104746917001459/a2231221z10-k.htm	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered:	CIFORADENANT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN
10.6 h OTHER https://www.sec.gov/Archives/edgar/data/1626971/000104746917001459/a2231221z10-k.htm	100 mg 2 times / day multiple, oral dose: 100 mg route of administration: Oral experiment type: MULTIPLE co-administered:	CIFORADENANT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN

PubMed

Title	Date	PubMed
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical Models.	2018-10	30131376
Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models.	2018-08	29923026

Substance Class	Chemical Created by `admin` on `Tue Apr 01 16:25:07 GMT 2025` Edited by `admin` on `Tue Apr 01 16:25:07 GMT 2025`
Record UNII	8KFO2187CP
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

3H-1,2,3-TRIAZOLO(4,5-D)PYRIMIDIN-5-AMINE, 7-(5-METHYL-2-FURANYL)-3-((6-((((3S)-TETRAHYDRO-3-FURANYL)OXY)METHYL)-2-PYRIDINYL)METHYL)-

Preferred Name

English

CIFORADENANT

Official Name

English

CIFORADENANT [USAN]

Common Name

English

V81444

Code

English

CPI-444

Code

English

Ciforadenant [WHO-DD]

Common Name

English

V-81444

Code

English

ciforadenant [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C2139